Pramosone

Pramosone Manufacturers

• Sebela Pharmaceuticals Inc.
  

  ×

  Pramosone | Sebela Pharmaceuticals Inc.

  

  ---

  DOSAGE AND ADMINISTRATION: Topical corticosteroids are generally applied to the affected area as a thin film three to four times daily depending on the severity of the condition. Lotion should be shaken well before use. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

  Close
  No Recall

  More Info
• Sebela Pharmaceuticals Inc.
  

  ×

  Pramosone | Sebela Pharmaceuticals Inc.

  

  ---

  DOSAGE AND ADMINISTRATION: Topical corticosteroids are generally applied to the affected area as a thin film three to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

  Close
  No Recall

  More Info
• Sebela Pharmaceuticals Inc.
  

  ×

  Pramosone | Sebela Pharmaceuticals Inc.

  

  ---

  DOSAGE AND ADMINISTRATION: Topical corticosteroids are generally applied to the affected area as a thin film three to four times daily depending on the severity of the condition. Lotion should be shaken well before use. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

  Close
  No Recall

  More Info
• Ferndale Laboratories, Inc.
  

  ×

  Pramosone | Target Corporation

  

  ---

  take every 4 to 6 hours do not take more than 6 doses in 24 hours swallow whole; do not crush, chew or dissolve adults and children 12 years of age and over  take 1 to 2 capsules  children 6 to under 12 years of age  take 1 capsule children under 6 years of age  do not use

  Close
  No Recall

  More Info
• Ferndale Laboratories, Inc.
  

  ×

  Pramosone | Costco Wholesale Company

  

  ---

  • if you are under 18 years of age, ask a doctor before use. No studies have been done to show if this product will work for you. • before using this product, read the enclosed User’s Guide for complete directions and other important information • begin using the lozenge on your quit day • if you smoke your first cigarette within 30 minutes of waking up, use 4 mg nicotine lozenge • if you smoke your first cigarette more than 30 minutes after waking up, use 2 mg nicotine lozenge according to the following 12 week schedule:

  Weeks 1 to 6

  Weeks 7 to 9

  Weeks 10 to 12

  1 lozenge every

  1 to 2 hours

  1 lozenge every

  2 to 4 hours

  1 lozenge every

  4 to 8 hours

  • nicotine lozenge is a medicine and must be used a certain way to get the best results • place the lozenge in your mouth and allow the lozenge to slowly dissolve (about 20-30 minutes). Minimize swallowing. Do not chew or swallow lozenge. • you may feel a warm or tingling sensation • occasionally move the lozenge from one side of your mouth to the other until completely dissolved (about 20-30 minutes) • do not eat or drink 15 minutes before using or while the lozenge is in your mouth • to improve your chances of quitting, use at least 9 lozenges per day for the first 6 weeks • do not use more than one lozenge at a time or continuously use one lozenge after another since this may cause you hiccups, heartburn, nausea or other side effects • do not use more than 5 lozenges in 6 hours. Do not use more than 20 lozenges per day. • it is important to complete treatment. If you feel you need to use the lozenge for a longer period to keep from smoking, talk to your health care provider.

  Close
  No Recall

  More Info
• Ferndale Laboratories, Inc.
  

  ×

  Pramosone | Deseret Biologicals, Inc.

  

  ---

  DIRECTIONS:  1-10 drops under the tongue, 3 times a day or as directed by a health professional.  Consult a physician for use in children under 12 years of age.
  

  Close
  No Recall

  More Info
• Ferndale Laboratories, Inc.
  

  ×

  Pramosone | Camber Pharmaceuticals, Inc.

  

  ---

  2.1 Dosage for Postherpetic Neuralgia

  In adults with postherpetic neuralgia, gabapentin may be initiated on Day 1 as a single 300 mg dose, on Day 2 as 600 mg/day (300 mg two times a day), and on Day 3 as 900 mg/day (300 mg three times a day). The dose can subsequently be titrated up as needed for pain relief to a dose of 1800 mg/day (600 mg three times a day). In clinical studies, efficacy was demonstrated over a range of doses from 1800 mg/day to 3600 mg/day with comparable effects across the dose range; however, in these clinical studies, the additional benefit of using doses greater than 1800 mg/day was not demonstrated.

  2.2 Dosage for Epilepsy with Partial Onset Seizures

  Patients 12 years of age and above

  The starting dose is 300 mg three times a day. The recommended maintenance dose of gabapentin tablets is 300 mg to 600 mg three times a day. Dosages up to 2400 mg/day have been well tolerated in long-term clinical studies. Doses of 3600 mg/day have also been administered to a small number of patients for a relatively short duration, and have been well tolerated. Administer gabapentin tablets three times a day using 600 mg or 800 mg tablets. The maximum time between doses should not exceed 12 hours.

  Pediatric Patients Age 3 to 11 years

  The starting dose range is 10 mg/kg/day to 15 mg/kg/day, given in three divided doses, and the recommended maintenance dose reached by upward titration over a period of approximately 3 days. The recommended maintenance dose of gabapentin in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses. The recommended maintenance dose of gabapentin in patients 5 to 11 years of age is 25 mg/kg/day to 35 mg/kg/day, given in three divided doses. Gabapentin may be administered as the oral solution, capsule, or tablet, or using combinations of these formulations. Dosages up to 50 mg/kg/day have been well tolerated in a long-term clinical study. The maximum time interval between doses should not exceed 12 hours.

  2.3 Dosage Adjustment in Patients with Renal Impairment

  Dosage adjustment in patients 12 years of age and older with compromised renal function or undergoing hemodialysis is recommended, as follows (see dosing recommendations above for effective doses in each indication):

  TABLE 1. Gabapentin Tablets Dosage Based on Renal Function

  Renal Function Creatinine Clearance

  (mL/min)

  Total Daily Dose Range

  (mg/day)

  Dose Regimen

  (mg)

  ≥60

  900-3600

  300 TID

  400 TID

  600 TID

  800 TID

  1200 TID

  >30-59

  400-1400

  200 BID

  300 BID

  400 BID

  500 BID

  700 BID

  >15-29

  200-700

  200 QD

  300 QD

  400 QD

  500 QD

  700 QD

  15a

  100-300

  100 QD

  125 QD

  150 QD

  200 QD

  300 QD

  Post-Hemodialysis Supplemental Dose (mg)b

  Hemodialysis

  125b

  150b

  200b

  250b

  350b

  TID = Three times a day; BID = Two times a day; QD = Single daily dose

  a For patients with creatinine clearance <15 mL/min, reduce daily dose in proportion to creatinine clearance (e.g., patients with a creatinine clearance of 7.5 mL/min should receive one-half the daily dose that patients with a creatinine clearance of 15 mL/min receive).

  b Patients on hemodialysis should receive maintenance doses based on estimates of creatinine clearance as indicated in the upper portion of the table and a supplemental post-hemodialysis dose administered after each 4 hours of hemodialysis as indicated in the lower portion of the table.

  Creatinine clearance (CLCr) is difficult to measure in outpatients. In patients with stable renal function, creatinine clearance can be reasonably well estimated using the equation of Cockcroft and Gault:

  The use of gabapentin tablets in patients less than 12 years of age with compromised renal function has not been studied.

  2.4 Dosage in Elderly

  Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and dose should be adjusted based on creatinine clearance values in these patients.

  2.5 Administration Information

  Administer gabapentin orally with or without food.

  Inform patients that, should they divide the scored 600 mg or 800 mg gabapentin tablet in order to administer a half-tablet, they should take the unused half-tablet as the next dose. Half-tablets not used within 28 days of dividing the scored tablet should be discarded.

  If the gabapentin dose is reduced, discontinued, or substituted with an alternative medication, this should be done gradually over a minimum of 1 week (a longer period may be needed at the discretion of the prescriber).

  Close
  No Recall

  More Info
• Ferndale Laboratories, Inc.
  

  ×

  Pramosone | Shift Consulting Group, Inc.

  

  ---

  Use only as directed

  Adults and children over 12 years of age apply to affected area not more than 3 to 4 times daily children under 12 years of age consult a physician.

  Close
  No Recall

  More Info
• Ferndale Laboratories, Inc.
  

  ×

  Pramosone | Ferndale Laboratories, Inc.

  

  ---

  Topical corticosteroids are generally applied to the affected areas as a thin film three to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressing should be discontinued and appropriate antimicrobial therapy instituted.

  Close
  No Recall

  More Info